Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Energy drinks with low caffeine content do not appear to adversely affect vascular functions, according to a study presented at this Congress.
The energy drink market is booming, with estimates that over 30% of 12-19 year-olds regularly use them, apparently undeterred by case reports linking energy drinks to fatal arrhythmias, ST segment elevation, Takotsubo cardiomyopathy, and aortic dissection. Or, for that matter, by studies suggesting that energy drinks increase blood pressure and platelet reactivity.
Cansin Tulunay Kaya, Cetin Erol, and colleagues, from Ankara University in Turkey explored the long-term consequences of energy drinks on CV health by documenting effects on endothelial dysfunction. ‘It’s well known that endothelial dysfunction plays an important role in the pathogenesis of atherosclerosis, hypertension and diabetes and could facilitate the atherosclerotic events that occur in late life,’ said Erol. ‘It can be used as an early warning signal since it begins well before other morphological changes.’
Thirty healthy volunteers had their brachial artery flow-mediated dilation (FMD) measured before drinking 355 ml of energy drink (containing 53.25 mg caffeine) and 60 minutes after consumption. FMD is the standard measure of endothelial function. Caffeine levels of 53.25 mg were selected since this is the legal level set in Turkey for commercially available energy drinks.
Results showed that systolic blood pressure, diastolic blood pressure and heart rate values were similar before and after energy drink consumption. Additionally, there was a 1.58% absolute decrease in FMD levels after consumption, but this did not reach statistical significance.
‘According to our study energy drinks with limited caffeine and taurine content don’t seem to have any influence on endothelial function,’ said Erol. ‘But these results should be interpreted with caution since the amount of caffeine and taurine in our protocol was lower than that used in commercially available products in many other countries.’
Turkey, he pointed out, is unusual in imposing legal limits on the amount of caffeine and taurine in drinks. Further studies exploring higher doses of caffeine and chronic use, he adds, should be undertaken before reaching definitive conclusions about the CV safety of energy drinks.’ Cardiologists should always ask young patients about their energy drink consumption, Erol warned.
Programme number P6478. Acute effects of energy drink consumption on endothelial function.
About the European Society of CardiologyThe European Society of Cardiology (ESC) represents more than 90 000 cardiology professionals across Europe and worldwide. Its mission is to reduce the burden of cardiovascular disease in Europe. About ESC Congress 2015ESC Congress is the world’s largest and most influential cardiovascular event contributing to global awareness of the latest clinical trials and breakthrough discoveries. ESC Congress 2015 takes place 29 August to 2 September at ExCel London in London, UK. Access the scientific programme. To access all the scientific resources from the sessions during the congress, visit ESC Congress 365.
© 2017 European Society of Cardiology. All rights reserved